Exploring the association of glioma tumor residuals from incongruent [<sup>18</sup>F]FET PET/MR imaging with tumor proliferation using a multiparametric MRI radiomics nomogram.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 37864593.
- Also identified by DOI 10.1007/s00259-023-06468-x.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The study aimed to using multiparametric MRI radiomics to predict glioma tumor residuals (TR<sub>FET over MR</sub>) derived from incongruent [<sup>18</sup>F]fluoroethyl-L-tyrosine ([<sup>18</sup>F]FET) PET/MR imaging. One hundred ten patients with gliomas who underwent [<sup>18</sup>F]FET PET/MR scanning were retrospectively analyzed. The TR<sub>FET over MR</sub> was identified by the discrepancy-PET that the extent of resection (EOR) based on MRI subtracted the biological tumor volume on PET images. The MRI parameters and radiomics features were extracted based on EOR and selected by the least absolute shrinkage and selection operator to construct radiomics score (Rad-score). The correlation network analysis of all features was analyzed by Spearman's correlation tests. The methods for evaluating the clinical usefulness consisted of the receiver operating characteristic curve, the calibration curve, and decision curve analysis. The Rad-score of the patients with the TR<sub>FET over MR</sub> was significantly higher than those with the non TR<sub>FET over MR</sub> (p < 0.001). The Rad-score was significantly correlated with the discrepancy-PET (r = 0.72, p < 0.001), Ki-67 level (r = 0.76, p < 0.001), and epidermal growth factor receptor (EGFR) of gliomas (r = 0.75, p < 0.001), respectively. Moreover, there was a difference of the correlation network analysis between the TR<sub>PET over MR</sub> group and non TR<sub>FET over MR</sub> group. The nomogram combing Rad-score and clinical features had the greatest performance in predicting TR<sub>FET over MR</sub> (AUC = 0.90/0.87, training/testing). There was a significant difference in prognosis (median OS, 17 m vs. 43 m) between patients with TR<sub>FET over MR</sub> and non TR<sub>FET over MR</sub> based on nomogram prediction (p < 0.001). The nomogram based on MRI radiomics would predict gliomas tumor residuals caused by the absence of <sup>18</sup>F-PET PET examination and adjust EOR to improve prognosis.
Medical subject headings
- Multiparametric Magnetic Resonance Imaging
- Brain Neoplasms
- Glioma